APA (7th ed.) Citation

WK, C., I, J., IJ, J., SY, S., SA, H., & KS, Y. Safety, Tolerability and Pharmacokinetics of Intravenous Sodium Taurodeoxycholate, HY209, a GPCR19 Agonist Inhibiting Inflammasomal Activation. Dove Medical Press.

Chicago Style (17th ed.) Citation

WK, Chung, Jeon I, Jang IJ, Seong SY, Han SA, and Yu KS. Safety, Tolerability and Pharmacokinetics of Intravenous Sodium Taurodeoxycholate, HY209, a GPCR19 Agonist Inhibiting Inflammasomal Activation. Dove Medical Press.

MLA (9th ed.) Citation

WK, Chung, et al. Safety, Tolerability and Pharmacokinetics of Intravenous Sodium Taurodeoxycholate, HY209, a GPCR19 Agonist Inhibiting Inflammasomal Activation. Dove Medical Press.